Literature DB >> 2045934

Brain perfusion is abnormal in cocaine-dependent polydrug users: a study using technetium-99m-HMPAO and ASPECT.

B L Holman1, P A Carvalho, J Mendelson, S K Teoh, R Nardin, E Hallgring, N Hebben, K A Johnson.   

Abstract

Cocaine abuse is widespread and has been associated with serious neurovascular complications. We studied a group of cocaine-dependent polydrug users with 99mTc-HMPAO and high-resolution SPECT and compared their perfusion pattern to cerebral perfusion in a group of older control subjects. Sixteen of 18 cocaine-dependent polydrug users had abnormal perfusion characterized primarily as small focal defects involving inferoparietal, temporal, and anterofrontal cortex and basal ganglia. Psychometric testing was abnormal in all 18 cocaine-dependent subjects. No relation was found between the severity of SPECT abnormalities and mode of administration or frequency or length of cocaine use. All 15 older normal subjects had normal cerebral perfusion. While the focal perfusion abnormalities to the cortex and basal ganglia could be explained by the profound vasoconstrictor effects of cocaine, the combinational use of multiple substances including cannabis and alcohol may play a contributory role. This study documents the high incidence of functional brain abnormalities in cocaine-dependent chronic polydrug users without corresponding abnormalities on imaging studies of cerebral anatomy and morphology.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2045934

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  23 in total

Review 1.  Neuroimaging in drug abuse.

Authors:  Kimberly P Lindsey; S John Gatley; Nora D Volkow
Journal:  Curr Psychiatry Rep       Date:  2003-10       Impact factor: 5.285

2.  Euphorigenic doses of cocaine reduce [123I]beta-CIT SPECT measures of dopamine transporter availability in human cocaine addicts.

Authors:  R T Malison; S E Best; E A Wallace; E McCance; M Laruelle; S S Zoghbi; R M Baldwin; J S Seibyl; P B Hoffer; L H Price
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

Review 3.  The role of cognitive control in cocaine dependence.

Authors:  Hugh Garavan; Robert Hester
Journal:  Neuropsychol Rev       Date:  2007-08-07       Impact factor: 7.444

Review 4.  Neurobiology of cocaine-induced organic brain impairment: contributions from functional neuroimaging.

Authors:  T L Strickland; B L Miller; A Kowell; R Stein
Journal:  Neuropsychol Rev       Date:  1998-03       Impact factor: 7.444

5.  Brain proton magnetic resonance spectroscopy and imaging in children exposed to cocaine in utero.

Authors:  L M Smith; L Chang; M L Yonekura; K Gilbride; J Kuo; R E Poland; I Walot; T Ernst
Journal:  Pediatrics       Date:  2001-02       Impact factor: 7.124

6.  Antiandrogen pretreatment alters cocaine pharmacokinetics in men.

Authors:  Rinah T Yamamoto; Christian J Teter; Tanya L Barros; Elissa McCarthy; Crystal Mileti; Trisha Juliano; Carissa L Medeiros; Alison Looby; Melissa A Maywalt; Jane F McNeil; David Olson; Gopinath Mallya; Scott E Lukas; Perry F Renshaw; Marc J Kaufman
Journal:  J Addict Med       Date:  2007-12       Impact factor: 3.702

Review 7.  Regional cerebral blood flow and cocaine abuse.

Authors:  K M Bell; N Milne; K P Lyons
Journal:  West J Med       Date:  1994-10

Review 8.  Nonhuman primate neuroimaging and the neurobiology of psychostimulant addiction.

Authors:  Leonard L Howell; Kevin S Murnane
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

9.  EEG and cerebral blood flow velocity abnormalities in chronic cocaine users.

Authors:  Marc L Copersino; Ronald I Herning; Warren Better; Jean-Lud Cadet; David A Gorelick
Journal:  Clin EEG Neurosci       Date:  2009-01       Impact factor: 1.843

10.  Gene expression profile of the nucleus accumbens of human cocaine abusers: evidence for dysregulation of myelin.

Authors:  Dawn N Albertson; Barb Pruetz; Carl J Schmidt; Donald M Kuhn; Gregory Kapatos; Michael J Bannon
Journal:  J Neurochem       Date:  2004-03       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.